Investing in Biotechnology Startups – Case of Anti-inflammatory Treatments

Loading Events

« All Events

  • This event has passed.

Investing in Biotechnology Startups – Case of Anti-inflammatory Treatments

July 1, 2019 @ 00:00

Join EBAN’s latest Health Webinar on Investing in Biotechnology Startups, led by Edward Vali, General Partner at Accelerate Venture Partners on July 1st at 14:00 CEST. The Webinar will focus on how health sciences are becoming more democratized and decentralized, hacking biotechnology investments is getting more accessible, obvious, and transparent. Investing in biotech is no longer reserved for specialized VCs and funds with deep pockets. This one hour webinar will discuss finding the right opportunities in responsible healthcare investing, focusing on investing in biotech companies.

Register Here

Speaker: Edward Vali

General Partner at Accelerate Venture Partners

Edward Vali is general partner at Accelerate Venture Partners, the investment and advisory arm of private family office with primary focus on transformative technologies, including applications of AI, blockchain, tokenized business models, and innovations in life sciences. Edward has been a contributor to the European Commission’s PRISM project on Intellectual Capital, particularly for healthtech companies in venture-backed investments.

Details

Date:
July 1, 2019
Time:
00:00
Event Category:
Are you an emerging Organisation?
We are Here To support You

Have additional questions?

Feel free to contact us under community@eban.org, and we will be more than happy to answer all of your questions.

Regular Price for Angel Networks
1.500€ per year
Price for Emerging Networks
1.000€ per year*
*Networks with less than 200 members or less than 10M invested per year
Regular Price for Angel Federations
2.500€ per year
Price for Emerging Federations
1.500€ per year*
*Federations with less than 200 affiliated angels or less than 3 BANs, VCs, or syndicates be part of their network
Regular Price for Early Stage Funds
2.500€ per year
Price for Emerging Early Stage Funds
1.500€ per year*
*Early Stage Funds with less than 20M AUM
Regular Price for Funding Platforms
2.500€ per year
Price for Emerging Funding Platforms
1.500€ per year*
*Platforms with less than 20M Euros of transactions made